1. Home
  2. CDT vs WLDS Comparison

CDT vs WLDS Comparison

Compare CDT & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • WLDS
  • Stock Information
  • Founded
  • CDT 2019
  • WLDS 2014
  • Country
  • CDT United States
  • WLDS Israel
  • Employees
  • CDT N/A
  • WLDS N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • WLDS Computer Communications Equipment
  • Sector
  • CDT Health Care
  • WLDS Telecommunications
  • Exchange
  • CDT Nasdaq
  • WLDS Nasdaq
  • Market Cap
  • CDT 2.2M
  • WLDS 2.0M
  • IPO Year
  • CDT N/A
  • WLDS 2022
  • Fundamental
  • Price
  • CDT $2.80
  • WLDS $1.53
  • Analyst Decision
  • CDT
  • WLDS
  • Analyst Count
  • CDT 0
  • WLDS 0
  • Target Price
  • CDT N/A
  • WLDS N/A
  • AVG Volume (30 Days)
  • CDT 618.7K
  • WLDS 461.5K
  • Earning Date
  • CDT 08-11-2025
  • WLDS 01-01-0001
  • Dividend Yield
  • CDT N/A
  • WLDS N/A
  • EPS Growth
  • CDT N/A
  • WLDS N/A
  • EPS
  • CDT N/A
  • WLDS N/A
  • Revenue
  • CDT N/A
  • WLDS $522,000.00
  • Revenue This Year
  • CDT N/A
  • WLDS N/A
  • Revenue Next Year
  • CDT N/A
  • WLDS N/A
  • P/E Ratio
  • CDT N/A
  • WLDS N/A
  • Revenue Growth
  • CDT N/A
  • WLDS 536.59
  • 52 Week Low
  • CDT $2.21
  • WLDS $1.20
  • 52 Week High
  • CDT $1,515.00
  • WLDS $47.92
  • Technical
  • Relative Strength Index (RSI)
  • CDT 38.74
  • WLDS 47.89
  • Support Level
  • CDT $2.57
  • WLDS $1.40
  • Resistance Level
  • CDT $3.05
  • WLDS $2.18
  • Average True Range (ATR)
  • CDT 0.23
  • WLDS 0.18
  • MACD
  • CDT 0.26
  • WLDS -0.00
  • Stochastic Oscillator
  • CDT 70.24
  • WLDS 18.75

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

Share on Social Networks: